TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10424185

Group type: EXPERIMENTAL
Intervention: Polyester clothing with low moisture absorption and low air permeability (A)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Polyester clothing with low moisture absorption and high air permeability (B)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cotton clothing with high moisture absorption and high air permeability (C)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All three kinds of clothing
Number of subjects: 3
Study: 7547617

Group type: EXPERIMENTAL
Intervention: Oral pancreatic enzyme supplements
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2237719

Group type: EXPERIMENTAL
Intervention: Meciadanol, 500 mg every six hours through a nasogastric tube
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Sucralfate, 1,000 mg every six hours through a nasogastric tube
Number of subjects: 298

Group type: COMPARATOR
Intervention: Antacid (Maalox), 15 ml every hour through a nasogastric tube
Number of subjects: 298
Study: 31512330

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CRE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo supplementation (PLA)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Equal duration trial following creatine supplementation (ISO)
Number of subjects: 11
Study: 28670677

Group type: EXPERIMENTAL
Intervention: Intraurethral lidocaine gel 2% plus intraglandular injection of lidocaine 2% (Group A)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Intraurethral lidocaine gel 2% alone (Group B)
Number of subjects: 156
Study: 25624309

Group type: EXPERIMENTAL
Intervention: WHISTLER-online
Number of subjects: 645

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 645
Study: 23021709

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) to the breast/chest wall and regional lymph nodes
Number of subjects: 32
Study: 21735653

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg once daily
Number of subjects: 98
Study: 18155752

Group type: EXPERIMENTAL
Intervention: Platelet aggregometry (PA) using adenosine diphosphate (ADP) and arachidonic acid (AA)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Impact‐R (Cone and Plate(let) Analyzer technology)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Impact‐R compared to PA
Number of subjects: 404
Study: 16615719

Group type: EXPERIMENTAL
Intervention: Video-game players
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Bilinguals
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control conditions (no conflict)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Simon task with conflict
Number of subjects: 97
Study: 12697573

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 10207

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 10207
Study: 10961749

Group type: EXPERIMENTAL
Intervention: Laparoscopic placement of the catheter (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open laparotomy technique (Group A)
Number of subjects: 50
Study: 9175687

Group type: EXPERIMENTAL
Intervention: Positive for anti-beta2GPI antibodies (group II)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Negative for both antibodies (group I)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Positive for aCL only (group III)
Number of subjects: 510
Study: 1337164

Group type: EXPERIMENTAL
Intervention: Interferon (3 x 10(6) units thrice weekly for the first 6 weeks, then twice weekly for a further 8 weeks)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Interferon and Control group
Number of subjects: 74
Study: 3989143

Group type: EXPERIMENTAL
Intervention: Epinephrine (0.25 and 0.50 nmol X kg‐1 X min‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Epinephrine (during allergen challenge)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Epinephrine (high dose)
Number of subjects: 8
Study: 30180054

Group type: EXPERIMENTAL
Intervention: Local steroid (40 mg of local triamcinolone)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: IV steroid (10 mg of IV dexamethasone)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (no steroid)
Number of subjects: 75
Study: 27491619

Group type: EXPERIMENTAL
Intervention: 3-weeks high-intensity training (HIT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 6-weeks high-intensity training (HIT)
Number of subjects: 18
Study: 24193232

Group type: EXPERIMENTAL
Intervention: CPR on floor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CPR on mattress
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CPR on backboards
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Feedback device on floor
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Feedback device with second sensor on mattress
Number of subjects: 24
Study: 22699134

Group type: EXPERIMENTAL
Intervention: Visual feedback condition (mirrors used)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control condition (mirrors covered)
Number of subjects: 25
Study: 20179689

Group type: EXPERIMENTAL
Intervention: High-definition chromocolonoscopy
Number of subjects: 660

Group type: COMPARATOR
Intervention: High-definition white light colonoscopy
Number of subjects: 660
Study: 19164187

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 750 microg twice daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 16120115

Group type: EXPERIMENTAL
Intervention: Mechanical periodontal treatment combined with systemic doxycycline, 100 mg day(‐1) for 14 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Neither periodontal treatment nor systemic doxycycline
Number of subjects: 52
Study: 12107836

Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg/m(2)) + Marimastat
Number of subjects: 239

Group type: COMPARATOR
Intervention: Gemcitabine (1000 mg/m(2)) + Placebo
Number of subjects: 239
Study: 10402383

Group type: EXPERIMENTAL
Intervention: Midazolam 0.06 mg/kg and Ketamine 0.75 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl 0.017 mg/kg, Propofol 2.5 mg/kg and Isoflurane
Number of subjects: 50
Study: 7530597

Group type: EXPERIMENTAL
Intervention: Bleomycin (0.03 unit/ml for 5 hours)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 153
Study: 2033221

Group type: EXPERIMENTAL
Intervention: Continuous nasogastric antacid infusion at 0.5 ml/min and i.v. injection of cimetidine 100 mg/h (treatment group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ranitidine 50 mg 8 hourly i.v. (control group)
Number of subjects: 25
Study: 7018363

Group type: EXPERIMENTAL
Intervention: Fixed combination tablet containing 5 mg of timolol, 25 mg of hydralazine, 25 mg of hydrochlorothiazide and 37.5 mg of triamterene
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31464811

Group type: EXPERIMENTAL
Intervention: Adjuvant mental practice using inverse video of the unaffected limb for 20 minutes before every session of rehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional occupational therapy alone
Number of subjects: 20
Study: 28296348

Group type: EXPERIMENTAL
Intervention: High-Brassica diet (6 portions of 84g broccoli, 6 portions of 84g cauliflower, 6 portions of 300g broccoli and sweet potato soup)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-Brassica diet (1 portion of 84g broccoli, 1 portion of 84g cauliflower)
Number of subjects: 10
Study: 25279816

Group type: COMPARATOR
Intervention: Original guidance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative guidance
Number of subjects: 0
Study: 23292233

Group type: EXPERIMENTAL
Intervention: Selenium (200 mcg twice daily)
Number of subjects: 77
Study: 22145499

Group type: EXPERIMENTAL
Intervention: 40 mg parecoxib sodium injection (treatment group; n = 133)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Normal saline (control group; n = 135)
Number of subjects: 268
Study: 19307511

Group type: EXPERIMENTAL
Intervention: Hormonal therapy duration more than 5 years
Number of subjects: 189

Group type: COMPARATOR
Intervention: Hormonal therapy duration less than or equal to 1 year
Number of subjects: 189

Group type: COMPARATOR
Intervention: Hormonal therapy duration more than 1 year and less than or equal to 5 years
Number of subjects: 189
Study: 15637558

Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (20 mL, 250 mug/mL, twice daily for 6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (20 mL, twice daily for 6 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11832528

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (basic rate, 15 beats per minute faster than the mean nocturnal sinus rate)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing
Number of subjects: 15
Study: 10076939

Group type: EXPERIMENTAL
Intervention: Low-dose glucocorticoid (prednisone at < 5 mg/day) for at least 12 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nonsteroidal anti‐rheumatic drugs (NSAIDs)
Number of subjects: 78
Study: 7720339

Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide infusion
Number of subjects: 9
Study: 1817904

Group type: EXPERIMENTAL
Intervention: Premedication with a combination of a neuroleptic drug and an opiate or a benzodiazepine
Number of subjects: 83

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Premedication
Number of subjects: 83
Study: 7449717

Group type: EXPERIMENTAL
Intervention: Zopiclone (10 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31863016

Group type: EXPERIMENTAL
Intervention: Repetitive electrical stimulation at 0.5 Hz, 1.1 Hz, and 1.6 Hz with pulse width of 1 ms at the bladder dome or trigone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repetitive electrical stimulation at 0.5 Hz
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Continuing stimulation
Number of subjects: 40
Study: 27613814

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ropivacaine for 24 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline infusion for 24 hours
Number of subjects: 100
Study: 25648969

Group type: EXPERIMENTAL
Intervention: Postoperative glenohumeral injection of bupivacaine (20mL) and lidocaine (10mL)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Postoperative injection administered in the subacromial space of bupivacaine (20mL) and lidocaine (10mL)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination of glenohumeral and subacromial injections of bupivacaine (20mL) and lidocaine (10mL)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Demerol as a postinjection rescue analgesic
Number of subjects: 121
Study: 24307267

Group type: EXPERIMENTAL
Intervention: VAC therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional dressing change
Number of subjects: 43
Study: 21278378

Group type: EXPERIMENTAL
Intervention: Interactive distraction
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Passive distraction
Number of subjects: 61

Group type: COMPARATOR
Intervention: No distraction control
Number of subjects: 61
Study: 19755697

Group type: EXPERIMENTAL
Intervention: Insulin alone
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Metformin only
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Metformin plus insulin
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo metformin
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 17530677

Group type: EXPERIMENTAL
Intervention: Multidisciplinary job retention vocational rehabilitation program
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual outpatient care
Number of subjects: 121
Study: 15300570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin 81 mg/day
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg combined with aspirin 81 mg/day
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg 3 times a day
Number of subjects: 1519
Study: 11214056

Group type: EXPERIMENTAL
Intervention: Low-dose rhTFPI (0.05 mg/ml)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: High-dose rhTFPI (0.15 mg/ml)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Heparin (100 U/ml)
Number of subjects: 622
Study: 9881389

Group type: EXPERIMENTAL
Intervention: Duraflo II equipment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Carmeda equipment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 8082100

Group type: EXPERIMENTAL
Intervention: Ondansetron (24 mg i.v.) in Study 1
Number of subjects: 346

Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v.) in Study 1
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg orally twice a day) for delayed emesis in Study 1
Number of subjects: 346

Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v.) for delayed emesis in Study 1
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Ondansetron (16 mg i.v.) in Study 2
Number of subjects: 346

Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v.) in Study 2
Number of subjects: 346
Study: 2644877

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg daily
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nifedipine 40 mg daily
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nifedipine (both doses)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22
Study: 1103213

Group type: EXPERIMENTAL
Intervention: Iron supplementation (30 to 240 mg of elemental iron as ferrous fumarate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron supplementation (120 mg of iron without B12 or folate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron supplementation (with vitamin B12 and folate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin B12 and folic acid alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron supplementation (120 mg or more)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 0
Study: 31027912

Group type: EXPERIMENTAL
Intervention: Independent practice with simulated mortality possible (n=12)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Independent practice without simulated mortality (n=12)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Support from attending physician with simulated mortality possible (n=12)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Support from attending physician without simulated mortality (n=12)
Number of subjects: 48
Study: 28431226

Group type: EXPERIMENTAL
Intervention: Ames Minilet™ Lancet
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Accriva Diagnostics Tenderfoot®
Number of subjects: 762

Group type: COMPARATOR
Intervention: Cardinal Health Gentleheel®
Number of subjects: 762

Group type: COMPARATOR
Intervention: Natus Medical NeatNick™
Number of subjects: 762

Group type: COMPARATOR
Intervention: BD Quikheel™ Lancet
Number of subjects: 762

Group type: COMPARATOR
Intervention: Vitrex Steriheel® Baby Lancet
Number of subjects: 762
Study: 26144389

Group type: EXPERIMENTAL
Intervention: Parenting intervention (12 fortnightly peer-led group sessions focusing on child care and maternal wellbeing)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control (waitlist with a brief message on nutrition)
Number of subjects: 194
Study: 23821088

Group type: EXPERIMENTAL
Intervention: Home BP telemonitoring and pharmacist case management
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 450
Study: 20975012

Group type: EXPERIMENTAL
Intervention: Barber-based intervention with continuous BP checks and peer-based health messaging
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard BP pamphlets
Number of subjects: 152
Study: 18095948

Group type: EXPERIMENTAL
Intervention: Program 1 (self-adjusted insulin dose)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Program 2 (investigator-reminded insulin dose)
Number of subjects: 78
Study: 15723384

Group type: EXPERIMENTAL
Intervention: Stimulant medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended-release delivery systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-line medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication adjustment
Number of subjects: 0
Study: 12230618

Group type: EXPERIMENTAL
Intervention: 3-month course of a gonadotrophin-releasing hormone analogue before surgery
Number of subjects: 126

Group type: COMPARATOR
Intervention: Radical prostatectomy only
Number of subjects: 126
Study: 9689831

Group type: EXPERIMENTAL
Intervention: Nabumetone (N)
Number of subjects: 170

Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 170
Study: 7808649

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg suppositories
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg suppositories
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo suppositories
Number of subjects: 99
Study: 2574192

Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl hydrochloride (HCl), 4 mg dose
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 4601508

Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 0.25 g
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 1 g
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 2 g
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Therapeutic dose of 4 g on the first day of illness
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Therapeutic dose of 8 g on the first day of illness
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Combination regimen (1 g daily and 4 g on the first day of illness)
Number of subjects: 2349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2349
Study: 30572875

Group type: EXPERIMENTAL
Intervention: Biological disease-modifying-antirheumatic-drug (DMARD) strategy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 30
Study: 26317483

Group type: EXPERIMENTAL
Intervention: Vitamin A palmitate eye gel 0.1%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carbomer eye gel 0.2%
Number of subjects: 30

Group type: COMPARATOR
Intervention: No additional application of vitamin A palmitate or carbomer gel
Number of subjects: 30
Study: 25270629

Group type: EXPERIMENTAL
Intervention: Cutamesine 1 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cutamesine 3 mg/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22765833

Group type: EXPERIMENTAL
Intervention: Ecallantide
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 21038648

Group type: EXPERIMENTAL
Intervention: Chinese medicine intestine adjusting therapy (IAT) with electro-acupuncturing and retention enema
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chinese medicine intestine adjusting therapy (IAT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional drug therapy and bi-level positive airway pressure ventilation
Number of subjects: 60
Study: 18724788

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Hispanic background
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Past suicide attempt
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Higher depression scores
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Higher cognitive scores
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 183
Study: 15807804

Group type: EXPERIMENTAL
Intervention: Automatic measurement using active contour algorithms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual measurement
Number of subjects: 0
Study: 11581481

Group type: EXPERIMENTAL
Intervention: 30 mg/kg acetaminophen loading dose
Number of subjects: 121

Group type: COMPARATOR
Intervention: 15 mg/kg acetaminophen maintenance dose
Number of subjects: 121
Study: 9682685

Group type: EXPERIMENTAL
Intervention: Workshops, materials, and ongoing advice for center leaders promoting implementation of a preventive services office system
Number of subjects: 5509
Study: 7978097

Group type: EXPERIMENTAL
Intervention: Nicotine dependence treatment (consultation, 10 intervention sessions, structured relapse prevention program)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Nicotine dependence treatment
Number of subjects: 101
Study: 2568064

Group type: EXPERIMENTAL
Intervention: Philips TL01 (new narrow-band UVB lamp)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Philips TL12 (standard UVB lamp)
Number of subjects: 29
Study: 31671276

Group type: EXPERIMENTAL
Intervention: EPA+DHA supplementation (600 mg EPA and 260 mg DHA per day for 8 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo group (matching capsules for the same duration of time)
Number of subjects: 19
Study: 27441600

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (6 g/day; 5:1 EPA:DHA)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (6 g/day corn/soy oil)
Number of subjects: 2
Study: 25871304

Group type: EXPERIMENTAL
Intervention: Best medical/surgical management plus daily supplementation of vitamin B6, vitamin B12, and folic acid
Number of subjects: 3247
Study: 23698211

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection (B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline solution) (S)
Number of subjects: 40
Study: 21854650

Group type: EXPERIMENTAL
Intervention: Krill oil (1680 mg EPA+DHA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fish oil rTAG (1680 mg EPA+DHA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fish oil EE (1680 mg EPA+DHA)
Number of subjects: 12